Literature DB >> 3103091

Pyruvate dehydrogenase complex deficiency as a cause of subacute necrotizing encephalopathy (Leigh disease).

H A Kretzschmar, S J DeArmond, T K Koch, M S Patel, C J Newth, K A Schmidt, S Packman.   

Abstract

Leigh disease is a disorder with great clinical variability and for which diverse biochemical causes have been proposed. Clarification requires rigorous correlation of biochemical abnormalities with strict morphologic diagnosis; such an unambiguous association is the subject of this report. A patient with well-documented clinical and biochemical pyruvate dehydrogenase complex deficiency is shown on postmortem examination to have the specific CNS pathology of Leigh disease. These findings, considered together with the aggregate data in the literature, suggest strongly that pyruvate dehydrogenase complex deficiency is the basic defect in a subgroup of patients with Leigh disease.

Entities:  

Mesh:

Year:  1987        PMID: 3103091

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  14 in total

Review 1.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2011-10-07       Impact factor: 4.797

2.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2012-07       Impact factor: 4.797

3.  Cytochrome c oxidase deficiency in subacute necrotizing encephalopathy (Leigh syndrome).

Authors:  K Hayasaka; G K Brown; D M Danks; M Droste; B Kadenbach
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

Review 4.  Neuropathology and pathogenesis of mitochondrial diseases.

Authors:  G K Brown; M V Squier
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 5.  Pyruvate dehydrogenase deficiency.

Authors:  G K Brown; L J Otero; M LeGris; R M Brown
Journal:  J Med Genet       Date:  1994-11       Impact factor: 6.318

6.  Neuropathological findings of a patient with pyruvate dehydrogenase E1 alpha deficiency presenting as a cerebral lactic acidosis.

Authors:  A Michotte; L De Meirleir; W Lissens; R Denis; J L Wayenberg; I Liebaers; J M Brucher
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Comparative biochemical studies in fibroblasts from patients with different forms of Leigh syndrome.

Authors:  M E Vazquez-Memije; S Shanske; F M Santorelli; P Kranz-Eble; E Davidson; D C DeVivo; S DiMauro
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

8.  Fatal lactic acidosis due to deficiency of E1 component of the pyruvate dehydrogenase complex.

Authors:  M A Birch-Machin; I M Shepherd; M Solomon; S J Yeaman; D Gardner-Medwin; H S Sherratt; J G Lindsay; A Aynsley-Green; D M Turnbull
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

9.  Heterogeneous expression of protein and mRNA in pyruvate dehydrogenase deficiency.

Authors:  I D Wexler; D S Kerr; L Ho; M M Lusk; R A Pepin; A A Javed; J E Mole; B W Jesse; T J Thekkumkara; G Pons
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

10.  Cytoplasmic transfer of the mtDNA nt 8993 T-->G (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio.

Authors:  I Trounce; S Neill; D C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.